Early Access Program for Zolbetuximab

Conditions:   Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer;   Locally Advanced Unresectable Gastric Adenocarcinoma Cancer;   Metastatic Gastric Adenocarcinoma Cancer;   Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention:   Drug: zolbetuximab Sponsor:   Astellas Pharma Global Development, Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials